密歇根2型糖尿病协作组织 (MCT2D):制定和实施全州范围的协作质量倡议
Lauren Oshman1, Neha Bhomia2, Heidi L Diez2
1University of Michigan, Ann Arbor, MI, USA. laoshman@med.umich.edu.
BMC health services research
|October 17, 2024
概括
密歇根2型糖尿病协会 (MCT2D) 正通过实施指南推的治疗方法来改善2型糖尿病 (T2D) 的护理. 这个全州范围的倡议涉及众多医生实践,以提高患者的治疗成果并降低医疗保健成本.
科学领域:
- 人口健康 人口健康
- 质量改善举措 质量改善举措
- 内分泌学和初级保健服务
背景情况:
- 2型糖尿病 (T2D) 是一种广泛的慢性疾病,与心脏病并发症和死亡率有关.
- 在遵守美国糖尿病协会对T2D护理的临床实践指南方面存在重大差距.
- 迫切需要有效的策略来改善符合指南的T2D护理的实施.
研究的目的:
- 建立一个全州的协作质量倡议 (CQI),以加强密歇根州的T2D护理.
- 实施基于证据的实践,以改善T2D患者的心脏和脏结局.
- 支持采用持续的葡萄糖监测和低碳水化合物饮食模式.
主要方法:
- 密歇根2型糖尿病协作 (MCT2D) 开发了一个学习健康系统,吸引了医生组织和实践.
- 倡议侧重于指导方针导向的药物治疗,持续的葡萄糖监测和饮食模式.
- 在2021-2022年期间招募了28个医生组织,拥有336个实践和1357名医生.
主要成果:
- 在2022年1月收集了96,140名2型糖尿病患者的基线数据.
- 66.3%的患者的HbA1c≤7.0%,而14.9%的人的HbA1c≥8.0%.
- 64.8%的患者的身体质量指数 (BMI) ≥30.0,表明肥胖.
结论:
- MCT2D成功组织了一场全州范围的合作活动,吸引了一大群多元化的医疗保健提供者.
- 该倡议为加速在全国范围内采用符合指南的T2D护理提供了一个有希望的模式.
- 未来的努力将致力于减少与糖尿病相关的并发症,医疗保健成本和T2D预防.
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...